$AYTU
AYTU BIOPHARMA, INC Stock $aytu

$aytu Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000155837022001110 Filed on February 14, 2022

Income Statement

Concept	2021 Q4	2020 Q4
Revenue	$23.13M	$15.15M
YoY Change	52.67%	377.07%
Cost Of Revenue	$10.83M	$6.251M
YoY Change	73.19%	931.44%
Gross Profit	$12.30M	$8.896M
YoY Change	38.25%	246.29%
Gross Profit Margin	53.18%	58.73%
Selling, General & Admin	$17.61M	$12.85M
YoY Change	37.04%	97.24%
% of Gross Profit	143.21%	144.48%
Research & Development	$4.920M	$286.0K
YoY Change	1620.28%	328.95%
% of Gross Profit	40.0%	3.21%
Depreciation & Amortization	$400.0K	$18.00K
YoY Change	2122.22%	-98.6%
% of Gross Profit	3.25%	0.2%
Operating Expenses	$23.59M	$14.47M
YoY Change	63.04%	119.83%
Operating Profit	-$11.29M	-$5.575M
YoY Change	102.58%	12.24%
Interest Expense	$20.00K	-$379.0K
YoY Change	-105.28%	-15.21%
% of Operating Profit
Other Income/Expense, Net	-$257.0K	-$3.950M
YoY Change	-93.49%	-183.11%
Pretax Income	-$11.55M	-$9.525M
YoY Change	21.27%	4435.71%
Income Tax	-$3.000K	$0.00
% Of Pretax Income
Net Earnings	-$11.55M	-$9.525M
YoY Change	21.24%	4345.8%
Net Earnings / Revenue	-49.94%	-62.88%
Basic Earnings Per Share	-$0.44	-$0.72
Diluted Earnings Per Share	-$0.44	-$0.72
COMMON SHARES
Basic Shares Outstanding	26.41M	13.28M
Diluted Shares Outstanding	26.41M	13.28M

Balance Sheet

Concept	2021 Q4	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$35.28M	$62.00M
YoY Change	-43.1%	1069.81%
Cash & Equivalents	$35.28M	$62.03M
Short-Term Investments
Other Short-Term Assets	$1.418M	$10.60M
YoY Change	-86.62%	158.51%
Inventory	$16.56M	$6.571M
Prepaid Expenses	$11.30M
Receivables	$22.99M	$7.001M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$87.50M	$92.54M
YoY Change	-5.44%	405.67%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.139M	$89.66K
YoY Change	8977.32%	-82.07%
Goodwill	$46.35M	$28.09M
YoY Change	65.0%
Intangibles	$81.34M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$457.0K	$0.00
YoY Change
Total Long-Term Assets	$136.3M	$74.20M
YoY Change	83.66%	32.04%
TOTAL ASSETS
Total Short-Term Assets	$87.50M	$92.54M
Total Long-Term Assets	$136.3M	$74.20M
Total Assets	$223.8M	$166.7M
YoY Change	34.23%	123.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$15.60M	$7.157M
YoY Change	118.02%	-25.45%
Accrued Expenses	$50.69M	$8.878M
YoY Change	470.92%	195.92%
Deferred Revenue	$200.0K	$475.7K
YoY Change	-57.95%
Short-Term Debt	$7.209M	$0.00
YoY Change
Long-Term Debt Due	$16.34M
YoY Change
Total Short-Term Liabilities	$100.6M	$25.81M
YoY Change	289.61%	62.35%
LONG-TERM LIABILITIES
Long-Term Debt	$129.0K	$0.00
YoY Change
Other Long-Term Liabilities	$560.0K	$11.37K
YoY Change	4824.81%	-99.97%
Total Long-Term Liabilities	$560.0K	$11.37K
YoY Change	4824.81%	-99.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$100.6M	$25.81M
Total Long-Term Liabilities	$560.0K	$11.37K
Total Liabilities	$118.3M	$54.05M
YoY Change	118.85%	-5.84%
SHAREHOLDERS EQUITY
Retained Earnings	-$217.7M	-$133.8M
YoY Change	62.66%
Common Stock	$323.2M	$1.788K
YoY Change	18077864.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$105.5M	$112.7M
YoY Change
Total Liabilities & Shareholders Equity	$223.8M	$166.7M
YoY Change	34.23%	123.81%

Cashflow Statement

Concept	2021 Q4	2020 Q4
OPERATING ACTIVITIES
Net Income	-$11.55M	-$9.525M
YoY Change	21.24%	4345.8%
Depreciation, Depletion And Amortization	$400.0K	$18.00K
YoY Change	2122.22%	-98.6%
Cash From Operating Activities	-$8.822M	-$2.930M
YoY Change	201.09%	-51.97%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$3.051M	-$30.00K
YoY Change	10070.0%	-99.39%
Cash From Investing Activities	-$3.051M	-$30.00K
YoY Change	10070.0%	-99.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$29.60M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	6.590M	27.08M
YoY Change	-75.66%	192.44%
NET CHANGE
Cash From Operating Activities	-8.822M	-2.930M
Cash From Investing Activities	-3.051M	-30.00K
Cash From Financing Activities	6.590M	27.08M
Net Change In Cash	-5.283M	24.12M
YoY Change	-121.9%	-1478.29%
FREE CASH FLOW
Cash From Operating Activities	-$8.822M	-$2.930M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2021Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26412473
CY2020Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13281904
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26003026
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12717180
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations
	dei	Entity Central Index Key EntityCentralIndexKey	0001385818
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
CY2021Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27490412
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30010468
CY2020Q4	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.72
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.52
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.09
CY2021Q2	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q2	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2021Q2	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38247
	dei	Entity Registrant Name EntityRegistrantName	AYTU BIOPHARMA, INC.
	dei	Entity Address Address Line1 EntityAddressAddressLine1	Delaware
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-0883144
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 206
	dei	Entity Address City Or Town EntityAddressCityOrTown	Englewood
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80112
	dei	City Area Code CityAreaCode	720
	dei	Local Phone Number LocalPhoneNumber	437-6580
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.0001
	dei	Trading Symbol TradingSymbol	AYTU
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30318168
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35277000
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	49649000
CY2021Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	252000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22989000
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	28176000
CY2021Q4	us-gaap	Inventory Net InventoryNet	16558000
CY2021Q2	us-gaap	Inventory Net InventoryNet	16339000
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	11298000
CY2021Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	9780000
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1418000
CY2021Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1038000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	87540000
CY2021Q2	us-gaap	Assets Current AssetsCurrent	105234000
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	4294000
CY2021Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	5140000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3845000
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3563000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	81339000
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	85464000
CY2021Q4	us-gaap	Goodwill Goodwill	46349000
CY2021Q2	us-gaap	Goodwill Goodwill	65802000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	457000
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	465000
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	136284000
CY2021Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	160434000
CY2021Q4	us-gaap	Assets Assets	223824000
CY2021Q2	us-gaap	Assets Assets	265668000
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	15604000
CY2021Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	19255000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	50685000
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	51295000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5041000
CY2021Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5939000
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	7209000
CY2021Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	7934000
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	16343000
CY2021Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	16668000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1173000
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	940000
CY2021Q4	aytu	Fixed Payment Arrangements Current FixedPaymentArrangementsCurrent	3310000
CY2021Q2	aytu	Fixed Payment Arrangements Current FixedPaymentArrangementsCurrent	3134000
CY2021Q2	aytu	Contingent Value Rights Liabilities Current ContingentValueRightsLiabilitiesCurrent	218000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1206000
CY2021Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	4055000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	100571000
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	109438000
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	129000
CY2021Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	180000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2716000
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2624000
CY2021Q4	aytu	Fixed Payment Arrangements Non Current FixedPaymentArrangementsNonCurrent	4623000
CY2021Q2	aytu	Fixed Payment Arrangements Non Current FixedPaymentArrangementsNonCurrent	6324000
CY2021Q4	aytu	Contingent Value Rights Liabilities Noncurrent ContingentValueRightsLiabilitiesNoncurrent	1392000
CY2021Q2	aytu	Contingent Value Rights Liabilities Noncurrent ContingentValueRightsLiabilitiesNoncurrent	1177000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	8297000
CY2021Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	8002000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	560000
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	355000
CY2021Q4	us-gaap	Liabilities Liabilities	118288000
CY2021Q2	us-gaap	Liabilities Liabilities	128100000
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2021Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30010468
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27490412
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	3000
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	3000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	323231000
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	315864000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-217698000
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-178299000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	105536000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	137568000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	223824000
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	265668000
CY2021Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23125000
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15147000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	45022000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	28667000
CY2021Q4	us-gaap	Cost Of Revenue CostOfRevenue	10826000
CY2020Q4	us-gaap	Cost Of Revenue CostOfRevenue	6251000
	us-gaap	Cost Of Revenue CostOfRevenue	20267000
	us-gaap	Cost Of Revenue CostOfRevenue	10314000
CY2021Q4	us-gaap	Gross Profit GrossProfit	12299000
CY2020Q4	us-gaap	Gross Profit GrossProfit	8896000
	us-gaap	Gross Profit GrossProfit	24755000
	us-gaap	Gross Profit GrossProfit	18353000
CY2021Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4920000
CY2020Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	286000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7016000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	469000
CY2021Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	9660000
CY2020Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5705000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	18957000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11531000
CY2021Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7953000
CY2020Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5584000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16169000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11004000
CY2020Q4	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1312000
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1312000
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	19453000
CY2021Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1060000
CY2020Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1584000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2153000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3169000
CY2021Q4	us-gaap	Operating Expenses OperatingExpenses	23593000
CY2020Q4	us-gaap	Operating Expenses OperatingExpenses	14471000
	us-gaap	Operating Expenses OperatingExpenses	63748000
	us-gaap	Operating Expenses OperatingExpenses	27485000
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-11294000
CY2020Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-5575000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-38993000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9132000
CY2021Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	20000
CY2020Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-379000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-20000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1130000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	277000
CY2020Q4	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	3313000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	496000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	3311000
CY2020Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-258000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-258000
CY2021Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-257000
CY2020Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3950000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-516000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4699000
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11551000
CY2020Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9525000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39509000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13831000
CY2021Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-110000
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-11548000
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-9525000
	us-gaap	Net Income Loss NetIncomeLoss	-39399000
	us-gaap	Net Income Loss NetIncomeLoss	-13831000
CY2021Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26412473
CY2020Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13281904
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26003026
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12717180
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.72
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.52
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.09
CY2021Q4	us-gaap	Shares Outstanding SharesOutstanding	30010468
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	105536000
CY2020Q4	us-gaap	Shares Outstanding SharesOutstanding	17882893
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	112693000
CY2021Q4	us-gaap	Shares Outstanding SharesOutstanding	30010468
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	105536000
CY2020Q4	us-gaap	Shares Outstanding SharesOutstanding	17882893
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	112693000
	us-gaap	Profit Loss ProfitLoss	-39399000
	us-gaap	Profit Loss ProfitLoss	-13831000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5352000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3905000
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	19453000
	us-gaap	Share Based Compensation ShareBasedCompensation	2748000
	us-gaap	Share Based Compensation ShareBasedCompensation	963000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	496000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	3311000
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-326000
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	132000
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	50000
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-112000
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	343000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-258000
	us-gaap	Inventory Write Down InventoryWriteDown	349000
	us-gaap	Inventory Write Down InventoryWriteDown	99000
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-86000
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	148000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5186000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1973000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	568000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3616000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1896000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1817000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3307000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3136000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-616000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1271000
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-51000
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	24000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12613000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10907000
	us-gaap	Payment For Contingent Consideration Liability Investing Activities PaymentForContingentConsiderationLiabilityInvestingActivities	3109000
	us-gaap	Payment For Contingent Consideration Liability Investing Activities PaymentForContingentConsiderationLiabilityInvestingActivities	43000
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	28000
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-4000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3137000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-39000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4825000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	32250000
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	172000
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	4293000
	aytu	Payments For Fixed Payment Arrangement PaymentsForFixedPaymentArrangement	2746000
	aytu	Payments For Fixed Payment Arrangement PaymentsForFixedPaymentArrangement	2786000
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	89632000
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	273000
	us-gaap	Proceeds From Issuance Of Long Term Debt And Capital Securities Net ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet	88857000
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-6000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1126000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24898000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-14624000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	13952000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49901000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48333000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35277000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	62285000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35277000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	62033000
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	252000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35277000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	62285000
	us-gaap	Interest Paid Net InterestPaidNet	2356000
	us-gaap	Interest Paid Net InterestPaidNet	307000
	aytu	Fixed Payment Arrangements Included In Accrued Liabilities FixedPaymentArrangementsIncludedInAccruedLiabilities	1050000
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1058000
	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	29000
	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	43000
	aytu	Warrants Issued WarrantsIssued	356000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35300000
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-11500000
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-9500000
	us-gaap	Net Income Loss NetIncomeLoss	-39400000
	us-gaap	Net Income Loss NetIncomeLoss	-13800000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-217700000
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-178300000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12600000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10900000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	87500000
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. In the accompanying consolidated financial statements, estimates are used for, but not limited to, stock-based compensation, revenue recognition, allowance for doubtful accounts, determination of variable consideration for accruals of chargebacks, administrative fees and rebates, government rebates, returns and other allowances, allowance for inventory obsolescence, valuation of financial instruments and intangible assets, accruals for contingent liabilities, fair value of long-lived assets, goodwill impairment, income tax provision, deferred taxes and valuation allowance, determination of right-of-use assets and lease liabilities, purchase price allocations, and the depreciable lives of long-lived assets. Because of the uncertainties inherent in such estimates, actual results may differ from those estimates. Management periodically evaluates estimates used in the preparation of the financial statements for reasonableness.</p>
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Prior Period Reclassification</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Certain prior year amounts in the consolidated balance sheets, statements of earnings and statements of cashflows have been reclassified to conform to the current year presentation, including a reclassification made in the presentation of FDA fees for commercialized product. This was previously included in general and administrative expenses and now is recorded as a component of cost of sales on the consolidated statements of earnings. These reclassifications did not affect operating earnings or other consolidated financial statements for the three and six months ended December 31, 2021 and 2020.</p>
CY2021Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	200000
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	100000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-100000
CY2020Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	45022000
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	52331000
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-39399000
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-23037000
CY2021Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	21000
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	200000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	200000
	aytu	Number Of Product Portfolios NumberOfProductPortfolios	3
	us-gaap	Inventory Write Down InventoryWriteDown	300000
	us-gaap	Inventory Write Down InventoryWriteDown	100000
CY2020Q4	us-gaap	Inventory Write Down InventoryWriteDown	0
CY2021Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23125000
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15147000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	45022000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	28667000
CY2021Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23125000
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15147000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	45022000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	28667000
CY2021Q4	us-gaap	Inventory Write Down InventoryWriteDown	100000
	us-gaap	Depreciation Depreciation	100000
CY2021Q4	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	100000
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	100000
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2427000
CY2021Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2269000
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2173000
CY2021Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3346000
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	11958000
CY2021Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	10724000
CY2021Q4	us-gaap	Inventory Net InventoryNet	16558000
CY2021Q2	us-gaap	Inventory Net InventoryNet	16339000
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	1840000
CY2021Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	1012000
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	4294000
CY2021Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	5140000
CY2021Q4	us-gaap	Depreciation Depreciation	400000
CY2020Q4	us-gaap	Depreciation Depreciation	18000
	us-gaap	Depreciation Depreciation	800000
CY2020Q4	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-100000
	us-gaap	Lessee Operating Lease Existence Of Option To Extend LesseeOperatingLeaseExistenceOfOptionToExtend	true
	us-gaap	Lessee Finance Lease Existence Of Option To Extend LesseeFinanceLeaseExistenceOfOptionToExtend	true
CY2021Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.180
CY2021Q4	us-gaap	Operating Lease Cost OperatingLeaseCost	330000
CY2020Q4	us-gaap	Operating Lease Cost OperatingLeaseCost	30000
	us-gaap	Operating Lease Cost OperatingLeaseCost	626000
	us-gaap	Operating Lease Cost OperatingLeaseCost	125000
CY2021Q4	us-gaap	Short Term Lease Cost ShortTermLeaseCost	26000
CY2020Q4	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2000
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	65000
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	5000
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	19000
CY2021Q4	us-gaap	Lease Cost LeaseCost	379000
CY2020Q4	us-gaap	Lease Cost LeaseCost	32000
	us-gaap	Lease Cost LeaseCost	736000
	us-gaap	Lease Cost LeaseCost	130000
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	8000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	50000
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	37000
CY2021Q4	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	4000
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	8000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3845000
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3563000
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	292000
CY2021Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	329000
CY2021Q4	aytu	Operating Lease And Finance Lease Right Of Use Asset OperatingLeaseAndFinanceLeaseRightOfUseAsset	4137000
CY2021Q2	aytu	Operating Lease And Finance Lease Right Of Use Asset OperatingLeaseAndFinanceLeaseRightOfUseAsset	3892000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1173000
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	940000
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	103000
CY2021Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	102000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2716000
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2624000
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	129000
CY2021Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	180000
CY2021Q4	aytu	Operating Lease And Finance Lease Liability OperatingLeaseAndFinanceLeaseLiability	4121000
CY2021Q2	aytu	Operating Lease And Finance Lease Liability OperatingLeaseAndFinanceLeaseLiability	3846000
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y1M2D
CY2021Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y5M1D
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y2M23D
CY2021Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y8M19D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0739
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0662
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0643
CY2021Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0641
	us-gaap	Operating Lease Payments OperatingLeasePayments	585000
CY2021Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	94220000
	us-gaap	Operating Lease Payments OperatingLeasePayments	125000
CY2021Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2600000
CY2021Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2600000
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2600000
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	94220000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12881000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	81339000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	708000
CY2021Q4	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	59000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1436000
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	104000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1379000
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	87000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	749000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	90000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	46000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4408000
CY2021Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	250000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	519000
CY2021Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	18000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3889000
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	232000
CY2021Q2	us-gaap	Goodwill Goodwill	65802000
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	19453000
CY2021Q4	us-gaap	Goodwill Goodwill	46349000
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2600000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8756000
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	85464000
CY2021Q2	aytu	Accrued Liabilities For Trade Partners AccruedLiabilitiesForTradePartners	5421000
CY2021Q4	aytu	Accrued Option Exercise And Milestone Fees Current AccruedOptionExerciseAndMilestoneFeesCurrent	3050000
CY2020Q4	aytu	Total Amortization Of Intangible Assets TotalAmortizationOfIntangibleAssets	1600000
	aytu	Total Amortization Of Intangible Assets TotalAmortizationOfIntangibleAssets	4100000
	aytu	Total Amortization Of Intangible Assets TotalAmortizationOfIntangibleAssets	3200000
CY2021Q4	aytu	Accrued Program Related Liabilities AccruedProgramRelatedLiabilities	10515000
CY2021Q2	aytu	Accrued Program Related Liabilities AccruedProgramRelatedLiabilities	8689000
CY2021Q4	aytu	Accrued Product Related Fees AccruedProductRelatedFees	1637000
CY2021Q2	aytu	Accrued Product Related Fees AccruedProductRelatedFees	2501000
CY2021Q4	aytu	Accrued Saving Offers AccruedSavingOffers	17995000
CY2021Q2	aytu	Accrued Saving Offers AccruedSavingOffers	20148000
CY2021Q4	aytu	Accrued Distributor Fees AccruedDistributorFees	3156000
CY2021Q2	aytu	Accrued Distributor Fees AccruedDistributorFees	2710000
CY2021Q4	aytu	Accrued Liabilities For Trade Partners AccruedLiabilitiesForTradePartners	4120000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	3914000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	7489000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	7333000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	7099000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	6331000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	6301000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	40272000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	78739000
CY2021Q4	aytu	Total Amortization Of Intangible Assets TotalAmortizationOfIntangibleAssets	2000000.0
CY2021Q2	aytu	Accrued Option Exercise And Milestone Fees Current AccruedOptionExerciseAndMilestoneFeesCurrent	600000
CY2021Q4	aytu	Medicaid Liabilities MedicaidLiabilities	1258000
CY2021Q2	aytu	Medicaid Liabilities MedicaidLiabilities	1714000
CY2021Q4	aytu	Return Reserve ReturnReserve	5781000
CY2021Q2	aytu	Return Reserve ReturnReserve	6367000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3173000
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3145000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	50685000
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	51295000
	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	2400000
CY2021Q4	us-gaap	Accretion Expense AccretionExpense	22000
CY2020Q4	us-gaap	Accretion Expense AccretionExpense	300000
	us-gaap	Accretion Expense AccretionExpense	100000
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	16104000
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	89000
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	39000
CY2021Q4	aytu	Long Term Debt And Capital Lease Obligations Gross LongTermDebtAndCapitalLeaseObligationsGross	16232000
CY2021Q4	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	240000
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	16343000
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	129000
CY2021Q4	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	300000
CY2020Q4	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	2400000
	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	500000
	us-gaap	Accretion Expense AccretionExpense	300000
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.52
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30010468
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27490412
CY2021Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	109588
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y25D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	9355
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	6.35
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	9502
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	8.10
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	90731
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	16.03
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y2M19D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	47838
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	22.99
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y2M1D
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	300000
CY2021Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1229000
CY2020Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	508000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2748000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	963000
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2021Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23125000
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15147000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	45022000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	28667000
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-11548000
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-9525000
	us-gaap	Net Income Loss NetIncomeLoss	-39399000
	us-gaap	Net Income Loss NetIncomeLoss	-13831000
CY2021Q4	us-gaap	Assets Assets	223824000
CY2021Q2	us-gaap	Assets Assets	265668000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3466974
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2862303
CY2021Q4	aytu	Asset Acquisition Milestone Amount Payable AssetAcquisitionMilestoneAmountPayable	2500000
CY2021Q4	aytu	Asset Acquisition Milestone Amount Payable AssetAcquisitionMilestoneAmountPayable	2500000
CY2020Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2021Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2

Files In Submission

Name	View Source	Status
0001558370-22-001110-index-headers.html	Edgar Link	pending
0001558370-22-001110-index.html	Edgar Link	pending
0001558370-22-001110.txt	Edgar Link	pending
0001558370-22-001110-xbrl.zip	Edgar Link	pending
aytu-20211231.xsd	Edgar Link	pending
aytu-20211231x10q.htm	Edgar Link	pending
aytu-20211231x10q001.jpg	Edgar Link	pending
aytu-20211231x10q_htm.xml	Edgar Link	completed
aytu-20211231xex10d1.htm	Edgar Link	pending
aytu-20211231xex10d2.htm	Edgar Link	pending
aytu-20211231xex10d3.htm	Edgar Link	pending
aytu-20211231xex10d4.htm	Edgar Link	pending
aytu-20211231xex10d5.htm	Edgar Link	pending
aytu-20211231xex10d6.htm	Edgar Link	pending
aytu-20211231xex31d1.htm	Edgar Link	pending
aytu-20211231xex31d2.htm	Edgar Link	pending
aytu-20211231xex32d1.htm	Edgar Link	pending
aytu-20211231_cal.xml	Edgar Link	unprocessable
aytu-20211231_def.xml	Edgar Link	unprocessable
aytu-20211231_lab.xml	Edgar Link	unprocessable
aytu-20211231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AYTU
AYTU BIOPHARMA, INC Stock $aytu

2021 Q4 Form 10-Q Financial Statement

#000155837022001110 Filed on February 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AYTU AYTU BIOPHARMA, INC Stock $aytu

2021 Q4 Form 10-Q Financial Statement

#000155837022001110 Filed on February 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AYTU
AYTU BIOPHARMA, INC Stock $aytu